International audienceBACKGROUND: Primary graft dysfunction remains the leading cause of 30-day mortality after heart transplantation. Few data have been published about the clinical outcome of severe primary graft dysfunction treated with venoarterial extracorporeal membrane oxygenation (VA-ECMO). AIM: To evaluate the prevalence and outcome of severe primary graft dysfunction requiring VA-ECMO, and to identify factors associated with hospital mortality. METHODS: We performed an observational analysis of our institutional database of VA-ECMO for primary graft dysfunction after heart transplantation. Patients with severe primary graft dysfunction, according to the International Society for Heart and Lung Transplantation classification, were ...
none11noEarly graft failure (EGF) is a major risk factor for death after heart transplantation (Htx)...
Objective: Data on patients requiring a second run of venoarterial extracorporeal membrane oxygenati...
International audienceBACKGROUND: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as dir...
International audienceBACKGROUND: Primary graft dysfunction remains the leading cause of 30-day mort...
International audienceBACKGROUND: The decision about whether to use venoarterial extracorporeal memb...
Background: Primary graft dysfunction is the main cause of early mortality after heart transplantati...
ObjectivesWe sought to analyze the indications and outcome of extracorporeal membrane oxygenation (E...
International audienceBackground Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is incre...
Copyright © 2013 Nai-Kuan Chou et al.This is an open access article distributed under the Creative C...
Introduction Peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) is one of the mo...
Background Primary graft dysfunction (P-GD) is the leading cause of early mortality after heart tran...
Background: The evidence of the benefits of using venoarterial extracorporeal membrane oxygenation (...
Background: The evidence of the benefits of using venoarterial extracorporeal membrane oxygenation (...
Abstract Background: The evidence of the benefits of using venoarterial extracorporeal membrane oxy...
none8noBackground: The occurrence of early graft failure (EGF) after heart transplantation (Htx) oft...
none11noEarly graft failure (EGF) is a major risk factor for death after heart transplantation (Htx)...
Objective: Data on patients requiring a second run of venoarterial extracorporeal membrane oxygenati...
International audienceBACKGROUND: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as dir...
International audienceBACKGROUND: Primary graft dysfunction remains the leading cause of 30-day mort...
International audienceBACKGROUND: The decision about whether to use venoarterial extracorporeal memb...
Background: Primary graft dysfunction is the main cause of early mortality after heart transplantati...
ObjectivesWe sought to analyze the indications and outcome of extracorporeal membrane oxygenation (E...
International audienceBackground Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is incre...
Copyright © 2013 Nai-Kuan Chou et al.This is an open access article distributed under the Creative C...
Introduction Peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) is one of the mo...
Background Primary graft dysfunction (P-GD) is the leading cause of early mortality after heart tran...
Background: The evidence of the benefits of using venoarterial extracorporeal membrane oxygenation (...
Background: The evidence of the benefits of using venoarterial extracorporeal membrane oxygenation (...
Abstract Background: The evidence of the benefits of using venoarterial extracorporeal membrane oxy...
none8noBackground: The occurrence of early graft failure (EGF) after heart transplantation (Htx) oft...
none11noEarly graft failure (EGF) is a major risk factor for death after heart transplantation (Htx)...
Objective: Data on patients requiring a second run of venoarterial extracorporeal membrane oxygenati...
International audienceBACKGROUND: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as dir...